VAERS reports by lot

Pfizer COVID-19 lot MD3414: VAERS reports

71 VAERS reports list lot MD3414 as a Pfizer COVID-19 vaccine, received between 2025-04-07 and 2026-02-02. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
71
Reports
10%
Marked serious
1
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4019%
General / Systemic (non-local)3919%
Neurological3216%
Cardiac / Cardiovascular2914%
Dermatological (non-injection-site)189%
Gastrointestinal178%
Musculoskeletal136%
Allergic / Anaphylactic52%
Respiratory52%
Psychiatric / Neuropsychiatric52%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Washington6
Texas5
Georgia5
Virginia4
Massachusetts4
Florida4
Illinois4
Minnesota3
Michigan3
Ohio3
Colorado3
California3

Reports by month received

MonthReportsBar
2025-0416
2025-0525
2025-0615
2025-077
2025-083
2025-093
2025-101
2026-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): LN8272 · LP1776 · LP1780 · ME6072 · MY9547 · MY9548

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.